FDA Orange Book
Generic for Vumerity
Vumerity contains diroximel. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Vumerity is diroximel. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Vumerity and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vumerity products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, delayed release, oral | 231MG | Marketed (Rx) | AB | 1 | AB |
NDA 211855, held by BIOGEN INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic diroximel
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| ZYDUS WORLDWIDE DMCC | 218596 | AB (A-rated, therapeutically equivalent) | November 12, 2025 | 231MG |
Vumerity patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9090558 | September 20, 2033 | Method of use | U-1384 | 211855 |
| 10080733 | September 20, 2033 | Drug substance, Drug product | U-1384 | 211855 |
| 8669281 | October 29, 2033 | Drug substance, Drug product | None | 211855 |
Vumerity NDC codes
Questions
Is there a generic for Vumerity?
Yes. The generic name for Vumerity is diroximel. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Vumerity?
The active ingredient in Vumerity is diroximel, per the FDA Orange Book.
When does the Vumerity patent expire?
The last patent listed for Vumerity in the Orange Book expires October 29, 2033. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.